LIAISON(®) Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study

INTRODUCTION: Fecal calprotectin (FC) is established as a diagnostic marker to differentiate between inflammatory bowel diseases and non‐inflammatory conditions. Furthermore, it may be effective in monitoring response to treatment, and to predict relapse during maintenance therapy. DESIGN: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorino, Gionata, Danese, Silvio, Peyrin‐Biroulet, Laurent, Sans, Miquel, Bonelli, Fabrizio, Calleri, Mariella, Zierold, Claudia, Pollastro, Roberta, Moretti, Fabio, Malesci, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557957/
https://www.ncbi.nlm.nih.gov/pubmed/35789124
http://dx.doi.org/10.1002/ueg2.12268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557957/
https://www.ncbi.nlm.nih.gov/pubmed/35789124
http://dx.doi.org/10.1002/ueg2.12268

Ejemplares similares